Olivia Brayer Saunders Analyst PerformanceAnalyst at Cantor FitzgeraldOlivia Brayer Saunders is a stock analyst at Cantor Fitzgerald focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Olivia Brayer Saunders has issued 31 stock ratings, including buy and hold recommendations. While full access to Olivia Brayer Saunders' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Olivia Brayer Saunders' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings61 Last 4 YearsBuy Recommendations88.52% 54 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution61RatingsDistribution of strong buy, buy, hold, and sell ratings by Olivia Brayer Saunders.RatingPercentageCount Strong Buy3.3%2 ratings Buy85.2%52 ratings Hold11.5%7 ratings Sell0.0%0 ratingsOut of 61 total stock ratings issued by Olivia Brayer Saunders at Cantor Fitzgerald, the majority (85.2%) have been Buy recommendations, followed by 11.5% Hold and 3.3% Strong Buy.Best & Worst CallsBest Call0000.0%GOSSSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%GOSSMay 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ92.3% of companies on NASDAQ24 companiesNYSEAMERICAN3.8% of companies on NYSEAMERICAN1 companyNYSE3.8% of companies on NYSE1 companyOlivia Brayer Saunders, an analyst at Cantor Fitzgerald, currently covers 26 companies listed on NASDAQ, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare24 companies92.3%Miscellaneous2 companies7.7%Olivia Brayer Saunders of Cantor Fitzgerald specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY16 companies61.5%PHARMACEUTICALS8 companies30.8%Miscellaneous2 companies7.7% Olivia Brayer Saunders' Ratings History at Cantor Fitzgerald Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIRLAQuince Therapeutics11/19/2026Reiterated Rating$40.59$70.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals11/17/2026Lower Price Target$159.73$205.00Neutral$0.0000.00% ROIMNKDMannKind11/6/2026Boost Price Target$3.76$10.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical11/3/2026Reiterated Rating$54.29Overweight$0.0000.00% ROIUTHRUnited Therapeutics10/26/2026Reiterated Rating$590.12$850.00Overweight$0.0000.00% ROIENSCEnsysce Biosciences10/20/2026Initiated Coverage$0.50$2.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/20/2026Reiterated Rating$54.67$86.00Overweight$0.0000.00% ROIMNKDMannKind10/20/2026Reiterated Rating$3.09$8.00Overweight$0.0000.00% ROIBRVEBraveheart Bio10/20/2026Reiterated Rating$19.21$40.00Overweight$0.0000.00% ROIOMEROmeros10/14/2026Reiterated Rating$18.88$22.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. UTHRUnited Therapeutics10/1/2026Reiterated Rating$541.89Overweight$0.0000.00% ROIOMEROmeros9/22/2026Upgrade$18.49$22.00Overweight$0.0000.00% ROIMNKDMannKind9/11/2026Reiterated Rating$3.79$8.00Overweight$0.0000.00% ROITENXTenax Therapeutics9/10/2026Reiterated Rating$2.06Overweight$0.0000.00% ROIBRVEBraveheart Bio8/31/2026Initiated Coverage$27.44$40.00Overweight$0.0000.00% ROIMISTMilestone Pharmaceuticals8/20/2026Initiated Coverage$1.08$3.00Overweight$0.0000.00% ROIIRLAQuince Therapeutics8/18/2026Reiterated Rating$34.12$70.00Overweight$0.0000.00% ROITENXTenax Therapeutics7/29/2026Reiterated Rating$15.80$35.00Overweight$0.0000.00% ROITENXTenax Therapeutics6/24/2026Reiterated Rating$13.64$35.00Overweight$0.0000.00% ROIIRLAQuince Therapeutics6/23/2026Initiated Coverage$18.55$80.00Overweight$0.0000.00% ROIIRLAQuince Therapeutics6/23/2026Initiated Coverage$19.36$80.00Overweight$0.0000.00% ROICNTBConnect Biopharma5/21/2026Initiated Coverage$2.31$4.00Overweight$0.0000.00% ROICNTBConnect Biopharma5/21/2026Initiated Coverage$2.36$4.00Overweight$0.0000.00% ROIPTHSPelthos Therapeutics4/1/2026Initiated Coverage$21.01$50.00Overweight$0.0000.00% ROIGOSSGossamer Bio3/23/2026Reiterated Rating$0.42Neutral$0.0000.00% ROITENXTenax Therapeutics3/17/2026Initiated Coverage$13.98$35.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics3/12/2026Boost Price Target$535.20$625.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics2/4/2026Boost Price Target$5.78$10.00Overweight$0.0000.00% ROIVNDAVanda Pharmaceuticals12/17/2025Reiterated Rating$6.93Overweight$0.0000.00% ROIINSMInsmed12/16/2025Boost Price Target$196.92$230.00Overweight$0.0000.00% ROIIKTInhibikase Therapeutics12/11/2025Initiated Coverage$1.48$4.00Overweight$0.0000.00% ROIVNDAVanda Pharmaceuticals10/30/2025Lower Price Target$4.51$11.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics9/22/2025Initiated Coverage$1.98$6.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics9/22/2025Initiated Coverage$2.06$6.00Overweight$0.0000.00% ROIGOSSGossamer Bio9/11/2025Reiterated Rating$3.11Overweight$00.0000.00% ROIUTHRUnited Therapeutics9/10/2025Boost Price Target$403.80$525.00Overweight$000.0000.00% ROIUTHRUnited Therapeutics6/2/2025Initiated Coverage$316.34$405.00Overweight$000.0000.00% ROIVNDAVanda Pharmaceuticals5/14/2025Reiterated Rating$3.92$13.00Overweight$0.0000.00% ROIVNDAVanda Pharmaceuticals5/13/2025Upgrade$3.88Strong-Buy$0.0000.00% ROIMESOMesoblast3/31/2025Upgrade$11.82Strong-Buy$00.0000.00% ROIMy $247 scanner for $7 (Ad)Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.Get the Instant Scanner for $7 in the Black Friday sale today.BMRNBioMarin Pharmaceutical2/20/2025Reiterated Rating$68.49$90.00Overweight$00.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Reiterated Rating$460.76$480.00Overweight$000.0000.00% ROIBMYBristol Myers Squibb2/4/2025Boost Price Target$60.03$55.00Neutral$00.0000.00% ROIVRTXVertex Pharmaceuticals1/31/2025Reiterated Rating$462.91$480.00Overweight$000.0000.00% ROIVRTXVertex Pharmaceuticals1/24/2025Reiterated Rating$439.97$480.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsRaymond James FinancialMizuhoStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.